ADSTILADRIN Trademark

Trademark Overview

On Friday, April 14, 2023, a trademark application was filed for ADSTILADRIN with the United States Patent and Trademark Office. The USPTO has given the ADSTILADRIN trademark a serial number of 97888081. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Monday, March 10, 2025. This trademark is owned by Ferring B.V.. The ADSTILADRIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations to treat cancer and bladder diseases; gene-based pharmaceutical products and preparations to treat cancer and bladder diseases
adstiladrin

General Information

Serial Number97888081
Word MarkADSTILADRIN
Filing DateFriday, April 14, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateMonday, March 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 11, 2024

Trademark Statements

Description of MarkThe mark consists of of the stylized wording "ADSTILADRIN" in black. Four stylized arrows arranged in a semicircle and pointing inwards appear to the left of the first "A." Counting clockwise, the first three arrows are in a blue gradient and the fourth arrow is in a yellow gradient.
Goods and ServicesPharmaceutical products and preparations to treat cancer and bladder diseases; gene-based pharmaceutical products and preparations to treat cancer and bladder diseases
Indication of Colors claimedThe color(s) black, blue, and yellow is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 9, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFerring B.V.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHoofddorp 2132JX
NL
Party NameFerring B.V.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHoofddorp 2132 JX
NL

Trademark Events

Event DateEvent Description
Tuesday, January 2, 2024NON-FINAL ACTION E-MAILED
Tuesday, April 18, 2023NEW APPLICATION ENTERED
Tuesday, May 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 10, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, January 2, 2024ASSIGNED TO EXAMINER
Tuesday, January 2, 2024NON-FINAL ACTION WRITTEN
Tuesday, January 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 11, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 11, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 11, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 26, 2024FINAL REFUSAL WRITTEN
Tuesday, March 26, 2024FINAL REFUSAL E-MAILED
Tuesday, March 26, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, April 22, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, April 22, 2024EXAMINERS AMENDMENT E-MAILED
Monday, April 22, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 22, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, May 7, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 22, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 11, 2024PUBLISHED FOR OPPOSITION
Monday, July 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 1, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, June 11, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, July 1, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, July 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 6, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 12, 2024SOU TEAS EXTENSION RECEIVED
Monday, August 12, 2024SOU EXTENSION 1 GRANTED
Monday, August 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 12, 2024SOU EXTENSION 1 FILED
Monday, March 10, 2025SOU TEAS EXTENSION RECEIVED
Monday, March 10, 2025SOU EXTENSION 2 FILED
Monday, March 10, 2025SOU EXTENSION 2 GRANTED
Tuesday, March 11, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

adstiladrin bladder diseases pharmaceutical cancer treat products preparations based gene